Diagnostic potential of cardiac natriuretic peptides in dialysis patients. - Wikidata - wikimedia - TriplyDB

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

http://www.wikidata.org/entity/Q48945446

about

Heart failure in patients with chronic kidney disease: a systematic integrative review Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.Biomarkers in predicting mortality and treatment in hemodialysis patients The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients Left ventricular dysfunction in the haemodialysis population.Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy.Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis Natriuretic peptides in chronic kidney disease.Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease.Natriuretic peptide testing in primary care patients.Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis.B-type natriuretic peptide is not a volume marker among patients on hemodialysis Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.Clinical utility of natriuretic peptides in dialysis patients.The diagnostic utility of cardiac biomarkers in dialysis patients.Impact of vascular access intervention therapy on cardiac load in hemodialysis patients.Brain natriuretic peptide and its relationship to left ventricular hypertrophy in patients on peritoneal dialysis or hemodialysis less than 3 years.Predictive abilities of baseline measurements of fluid overload, assessed by bioimpedance spectroscopy and serum N-terminal pro-B-type natriuretic peptide, for mortality in hemodialysis patients.Role of B-type natriuretic peptide as a marker of mortality in acute kidney injury patients treated with continuous renal replacement therapy.Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures.Relationship of plasma Dendroaspis natriuretic peptide-like immunoreactivity and echocardiographic parameters in chronic haemodialysis patients.Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis.Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis.Evaluation of atrial and brain natriuretic polypeptides in association with angiotensin-converting enzyme gene polymorphism in Japanese non-diabetic hemodialysis patients.Nt-proBNP in haemodialysis patients: a preliminary study.Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.Change in cardiovascular disease status in peritoneal dialysis patients: a 5-year single-center experience.Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients

P2860

Q26824149-D5D9FA40-08E4-4E9E-80FE-4E345682C72D Q33227738-32635363-7A97-4702-8AAE-CE6DB9F62CBF Q34062442-2877E989-53A1-4A32-A14C-D6D41E29F56E Q34346282-ADC7AFA3-CB61-4B9C-A4DC-09AEFE20640E Q35131225-1888EC61-1322-4457-8BC7-582E439B3521 Q35278624-CB208AD1-B57F-4D31-BD91-7D64F8B4C232 Q35573726-C612E403-0527-4108-A8F1-00077A225E82 Q36108948-E2D9A421-FC7B-4268-83C0-5348ACAD6557 Q36317204-8DB79C07-BABE-491B-B036-3FBF5CE197F6 Q36666782-1F80B820-32E5-47A5-B78E-A8E1B53C39A3 Q36736728-60F50387-6860-4534-8833-E6F839700211 Q36947290-5E661456-8597-40B3-B2C5-34C077452D25 Q37205455-188AE8D8-91EE-4073-AFB7-07EAAB87750A Q37291305-F7460D91-230C-4D42-A7FC-BE7E93D86569 Q37313438-E17C21FD-995B-426C-9060-92507A790119 Q37349694-8DBE1704-8B41-45D6-92FA-EEFDCE464603 Q37845928-D4550A76-D8B3-457D-832A-A3776068AE1C Q38011232-18BB84B6-5675-4900-96DB-9024D93C0A93 Q38022786-21F74B19-F69C-42A7-B0CF-95366D771A56 Q39350457-F3D9DAE0-3D7F-4350-ABEF-F9C9D2F7BF7B Q40342804-7420245E-6DA3-47DE-A7DC-7065D9589E88 Q41549705-146FF4B6-08C5-494B-92EA-7D5BE47134AB Q43432354-63CEB14E-885F-490A-B939-0955788990E3 Q44664419-63AFC826-F9D1-422D-8DE5-167BDBE51585 Q44930535-EF9EE31E-7D3C-4E63-82F8-3A0530D8C561 Q46213382-9AFE8AB4-4B67-4D3E-9254-4D0583D1D130 Q48171303-29F1CAA1-8B78-4D19-8B1A-EAABC42AF2E5 Q48190743-7CEA3398-AD9C-4534-A2BA-1446B68D7931 Q48786001-E4AC5E7F-4C24-427A-969E-B2FDB4069549 Q48875117-762DD32A-26DA-4DB8-97F7-33919FAF9DAA Q50502242-F43DB123-19BA-4AF6-A679-F2180E6461E7 Q50991537-E3CB0354-CF92-404F-A14C-DCF2D31802FA Q53003009-C5E13B44-6550-4849-B0C6-0B4F169B7E56 Q57750151-5C5217AD-7584-4F56-8838-50CF0C844F7E Q58564998-96DBFC44-D8F9-40FC-BFC6-3514ACCF43B8

P2860

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

http://www.wikidata.org/entity/Q48945446

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@en

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@nl

type

label

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@en

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@nl

prefLabel

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@en

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@nl

P1433

Q48945446-A80418CB-D335-4807-BF65-309E12D6DD5C

P1476

Q48945446-22A8AABF-CBD8-4E63-A1C5-FDCFB5D161EE

P2093

Q48945446-1BE83795-7264-4031-8EC1-D0A5CFBAE3E9

Q48945446-337CB273-D4FA-4890-8EC8-657162F50ECC

Q48945446-598205A1-1C7B-4E0B-B2C4-5733163A799A

Q48945446-5A5DF723-41BC-4AA6-AE3C-7B00B164AF2A

Q48945446-5DE16F96-3353-493D-A6E3-B7EEC3EAE125

Q48945446-6E0B9542-558C-49FA-AFD6-5BA6144ADF40

Q48945446-73996123-BFB5-4403-86AC-DF6FDC2F0613

Q48945446-78ABCC8B-1947-4FF3-BD78-EED79A0D0404

Q48945446-C9D5FDA4-A610-441D-98CD-09DB56B84D06

Q48945446-CB6F0DD5-F211-478A-B933-9B31FFD0F999

P2888

Q48945446-55BB6D38-9C8C-4CDA-8862-FDDE575B483A

P304

Q48945446-45FC95E5-EE2E-4B39-9E72-05538E179540

P31

Q48945446-258EB03C-422B-4DAA-86B7-517783756879

P356

Q48945446-75E6F0AC-2DF6-4B9E-8CE3-98D6CD9A8605

P407

Q48945446-AA6B50D7-6386-498F-9DF4-FD8B63D82CAA

P433

Q48945446-5C44ABC3-ADF0-4487-8861-3B8E31E9C5B7

P478

Q48945446-EA56D97B-A3E6-441E-AD45-E75D3E491F84

P50

Q48945446-E6ABF493-BD8D-4BFE-B331-1D66444C3339

Q48945446-FF809F22-888C-4118-9ADE-D95E6AFD4BE7

P577

Q48945446-23E78B54-4D6F-423F-8B48-C60700B07B07

P5875

Q48945446-48CD78A1-A2E3-4A29-8C1C-84A4076EA225

P6179

Q48945446-DB1FA04D-2350-4F6A-8072-113199BC5D34

P698

Q48945446-CF54B867-B460-4F03-BA18-58C213DC3A9F

P921

Q48945446-02961B74-D75D-4827-B0B9-57A825E2B906

Q48945446-2DF9F039-C823-478E-8292-C66FB0D2693F

P356

J.1523-1755.2001.0590041559.X

P1433

Kidney International

P1476

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

@en

P2093

A Cataliotti

http://www.w3.org/2001/XMLSchema#string

CREED Investigstors. The Cardiovascular Risk Extended Evaluation

http://www.w3.org/2001/XMLSchema#string

F A Benedetto

http://www.w3.org/2001/XMLSchema#string

F Mallamaci

http://www.w3.org/2001/XMLSchema#string

G Giacone

http://www.w3.org/2001/XMLSchema#string

G Tripepi

http://www.w3.org/2001/XMLSchema#string

I Bellanuova

http://www.w3.org/2001/XMLSchema#string

L S Malatino

http://www.w3.org/2001/XMLSchema#string

S Cutrupi

http://www.w3.org/2001/XMLSchema#string

S Parlongo

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2001.0590041559.x

P304

1559-1566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1523-1755.2001.0590041559.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Carmine Zoccali

Benedetta Stancanelli

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12073111

http://www.w3.org/2001/XMLSchema#string

P6179

1002297402

http://www.w3.org/2001/XMLSchema#string

P698

11260421

http://www.w3.org/2001/XMLSchema#string

P921